ReviewJugan geon-gang gwa jilbyeong2025
Korean HIV/AIDS Cohort Study: Past Achievements, Present Directions, and Future Perspectives.
Review in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Commemoration of the Special Issue on HIV/AIDS in "Jugan geon-gang gwa jilbyeong · 2025Article
- HIV/AIDS Management Programs in Republic of Korea: Achievements and Future Direction.Jugan geon-gang gwa jilbyeong · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The Korea human immunodeficiency virus/acquired immunodeficiency syndrome, (HIV/AIDS) Cohort Study, initiated in 2006, has been performed to systematically analyze the natural history, treatment responses, complications, drug resistance, and psychosocial factors among people living with HIV (PLHIV) to provide an evidence-based description of disease progression and guidance for disease management. Methods: Since inception of the study in 2006, 21 hospitals have participated, with 15 hospitals actively involved as of 2025. A single epidemiological data center continuously from the early stages of the research, responsible for standardized data collection, quality management, epidemiological consultation, and statistical support. The study includes research on rapid treatment initiation, immune recovery, transmission routes, and non-infectious complications. Results: This research has contributed to improving the survival rate and quality of life among PLHIV by systematically analyzing various factors. Introduction of pre-exposure prophylaxis (PrEP), development of mathematical models to guide policy formulation, and establishment of a high-quality standardized data management system also provide a crucial foundation for future HIV research and policy advancement. Conclusions: Through national big data linkage and sharing, this study is expected to enhance domestic and international research activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.